99mTc-H7ND SPECT/CT Imaging in NSCLC

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 13, 2023

Primary Completion Date

August 10, 2025

Study Completion Date

August 10, 2026

Conditions
NSCLC
Interventions
DIAGNOSTIC_TEST

99mTc-H7ND SPECT/CT imaging performed

99mTc-H7ND SPECT/CT imaging positive (+) was defined as the presence of at least one measurable lesion and the uptake of the lesion was greater than that of normal liver in the experimental group, and patients were divided into SD+ and SD-. According to the guidelines and routine clinical practice, SD- patients were treated with the original regimen or maintenance treatment, and SD+ patients were divided into continuation of the original regimen or second-line treatment according to the MDT discussion results.

Trial Locations (1)

710061

RECRUITING

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER